retatrutide good for liver is being talked about as the next big weight loss peptide. But a Victorian Government health warning over the weekend has linked products sold as 'Retatrutide' to six cases of acute retatrutide nonalcoholic steatohepatitis nash trial

Kenneth McCall suggests that compounded GLP-1s pose may more safety issues than their manufactured counterparts

Matching the tool to the type of pain instead of taking everything at once is the part most people skip entirely

Case Updates July 2024 On July 14, 2024, Judge Karen Spencer Marston issued several case management orders (CMOs) in the GLP-1RAs Product Liability MDL

The American Diabetes Association (ADA) recommends GLP-1 receptor agonists with proven cardiovascular benefit as preferred agents for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or indicators of high cardiovascular risk